Diasorin | DIA - Cost Of Sales

Stock Price
69.70
Daily Change
-0.78 -1.11%
Monthly
10.53%
Yearly
-25.55%
Q2 Forecast
68.63

Diasorin reported EUR101M in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Amplifon EUR -241.7M 701.87M Dec/2025
Avanos Medical USD 88M 6.9M Mar/2026
Brookdale Senior Living USD 643.31M 41M Dec/2025
Cencora USD 83.12B 2.35B Dec/2025
Diasorin EUR 101M 7.58M Mar/2026
Encompass Health USD 151.6M 700K Mar/2026
Enovis USD 265.57M 5.95M Mar/2026
GE HealthCare Technologies USD 3.44B 283M Dec/2025
OPKO Health USD 103.48M 1.3M Dec/2025
Veradigm USD 124.74M 56.25M Dec/2022
Zimmer Biomet Holdings USD 738.3M 231.8M Mar/2026